Difficulty: Medium
Average Score: 93%
Practice
Which of the following medications is used to prevent blood clot formation in patients with a-fib or pulmonary embolism, and decrease the risk of MI in patients with atherosclerosis as well as reduce the risk of stroke?
Correct answer
C
Rationale
Rationale:
C: Losartan is an angiotensin II receptor blocker used to prevent blood clot formation in a-fib/pulmonary embolism, decrease MI risk in atherosclerosis, and reduce stroke risk by lowering blood pressure and improving cardiovascular outcomes.
Incorrect choices:
A: Nitroglycerin is a vasodilator used for angina but does not prevent blood clot formation or reduce stroke risk.
B: Lotensin is an ACE inhibitor for hypertension, not specifically for preventing blood clots or reducing stroke risk.
D: Streptokinase is a thrombolytic agent used to dissolve blood clots, not prevent their formation.
C: Losartan is an angiotensin II receptor blocker used to prevent blood clot formation in a-fib/pulmonary embolism, decrease MI risk in atherosclerosis, and reduce stroke risk by lowering blood pressure and improving cardiovascular outcomes.
Incorrect choices:
A: Nitroglycerin is a vasodilator used for angina but does not prevent blood clot formation or reduce stroke risk.
B: Lotensin is an ACE inhibitor for hypertension, not specifically for preventing blood clots or reducing stroke risk.
D: Streptokinase is a thrombolytic agent used to dissolve blood clots, not prevent their formation.